RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening

Sponsor
Harvard Pilgrim Health Care (Other)
Overall Status
Completed
CT.gov ID
NCT00792285
Collaborator
(none)
80,000
1
2
12
6671.2

Study Details

Study Description

Brief Summary

This large randomized controlled trial is testing the effectiveness of automated telephone outreach with speech recognition to improve rates of screening for colorectal cancer. The hypothesis is that the intervention improves rates of screening overall and specifically rates of colonoscopy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Automated Telephone Outreach with Speech Recognition
N/A

Detailed Description

Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in the United States. Despite widespread dissemination of evidence-based guidelines recommending CRC screening, a large proportion of eligible individuals do not undergo screening. A variety of interventions have been tested to increase screening in primary care, but there remains an urgent imperative to develop and evaluate cost-effective and widely applicable approaches to promoting screening. In March 2005, Harvard Pilgrim Health Care, a large non-profit HMO in New England, carried out an internally funded program to increase CRC screening. The HMO randomized 80,000 members aged 50 to 64 years to receive automated telephone outreach with speech recognition or usual care. The intervention entailed the telephone engagement of members in a dialogue with a computer-programmed, responsive human voice about the importance of CRC screening, the options for undergoing screening, and encouragement to follow-up with their primary care physicians. The present study involves a 12-month follow-up of all eligible members randomized to intervention or usual care in March 2005, with assessment of the effect of the intervention on rates of CRC screening. This study has important implications for increasing CRC screening. With health plans expanding efforts to screen large populations for CRC and other malignancies, automated telephone outreach with speech recognition can reach large numbers of individuals with educational and reminder messages. It is important to know whether these efforts to promote screening are effective in overcoming known disparities in screening for CRC. If proven effective and cost-effective, this technology has the potential for widespread adoption and population-wide improvements in CRC screening and other prevention-related behaviors, with the ultimate public health goal of reducing the burden of suffering attributable to cancer and its complications.

Study Design

Study Type:
Interventional
Actual Enrollment :
80000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Automated Telephone Outreach With Speech Recognition to Improve Colorectal Cancer Screening: A Randomized Controlled Trial
Study Start Date :
Mar 1, 2005
Actual Primary Completion Date :
Mar 1, 2006
Actual Study Completion Date :
Mar 1, 2006

Arms and Interventions

Arm Intervention/Treatment
Experimental: Automated Telephone Outreach

Automated Telephone Outreach with Speech Recognition

Behavioral: Automated Telephone Outreach with Speech Recognition
Automated Telephone Outreach with Speech Recognition calls to health plan members to promote screening

No Intervention: Usual Care

Usual Care

Outcome Measures

Primary Outcome Measures

  1. colorectal cancer screening [one year]

Secondary Outcome Measures

  1. colonoscopy screening [one year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 50-64 at baseline

  • Continuous enrollment in health plan

Exclusion Criteria:
  • Prior request for exclusion from research or quality improvement

  • No telephone number on file

  • Enrolled in other telephone-based outreach program of the health plan

  • Share household with another eligible member

  • Evidence of colorectal cancer or polyps at baseline

  • Evidence of prior screening at baseline such that screening is not due at time of intervention

Contacts and Locations

Locations

Site City State Country Postal Code
1 Harvard Pilgrim Health Care Boston Massachusetts United States 02215

Sponsors and Collaborators

  • Harvard Pilgrim Health Care

Investigators

  • Principal Investigator: Steven R Simon, MD, Harvard Pilgrim Health Care

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00792285
Other Study ID Numbers:
  • ATO-SR CRC
First Posted:
Nov 17, 2008
Last Update Posted:
Nov 17, 2008
Last Verified:
Nov 1, 2008
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 17, 2008